About Our COVID-19 Tests
We offer testing to determine whether you may be currently infected with COVID-19 through diagnostic molecular testing, or an Active Infection Test. This swab test is appropriate if you:
- are experiencing and COVID-19 symptoms such as fever, cough, shortness of breath, sore throat or generally feeling weak.
- have been exposed to COVID-19 in the last 14 days.
In addition, we offer antibody testing to see whether antibodies may be present from previous exposure. It is important to remember that these tests are new and the meaning of the results is not fully understood. You should not use the results of this test to determine if you can safely return to work.
A positive test may not mean you:
- are protected from the virus in the future or that you are no longer infectious.
- were infected by COVID-19 virus; it may detect antibodies to coronaviruses that cause the harmless "common cold," to other viruses, or simply be false ("false positive").
A negative test does not mean you have not been exposed to the virus or that you cannot infect others.
Further study may identify the most useful test in the future, but currently we don’t know which test will provide the best information. It is important that you are aware that you may be liable for payment as it is not clear whether testing will be paid for by insurance or Medicare/Medicaid. This information is current as of April 28, 2020. We will continue to track improvements and share updated information.
Antibodies are proteins made by your body’s immune system to fight viruses. These antibodies are attacking specific places on the surface of the virus.
A positive test means that you may have been exposed to the virus causing COVID-19 (SARS-CoV-2). It is possible some of the tests are going to detect other viruses that are common in the community or simply be falsely positive. If you have had an illness compatible with COVID-19 infection, a positive test is more likely to be correct.
Not necessarily. We don’t know yet which antibodies protect against getting COVID-19. In addition, some people making these antibodies still have virus in their nose, suggesting they could still be infectious.
No. Not all people make antibodies to the virus. The current information suggests that up to 2% of people who had COVID-19 do not make antibodies. Some of these people have weaker immune systems, but some people have normal immune systems and had only mild symptoms of COVID-19.
Download a PDF of our complete statement on serologic (blood) testing for COVID-19 antibodies.
- Abbott Alinity m SARS-CoV-2 Assay
- Abbott ID Now
- BD SARS-CoV-2 Assay (standalone)
- BD SARS-CoV-2 Flu Assay (COVID/Flu)
- BioGX SARS-CoV-2 Reagents for the BD Max System*
- BioFire Respiratory Panel 2.1 Panel
- CDC 2019-nCoV Real-Time-RT-PCR Diagnostic Panel
- Cepheid Xpert Xpress SARS-CoV-2
- Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV
- Cepheid Xpert Xpress CoV-2/Flu/RSV plus
- Diasorin Simplexa COVID-19 Direct Assay
- Hologic Aptima SARS-CoV-2 Assay
- Luminex ARIES® SARS‑CoV‑2 Assay
- QIAGEN QIAstat-Dx Respiratory SARS-CoV-2 Panel
- Roche cobas SARS-CoV-2
- Roche cobas SARS-CoV-2 & Influenza A/B
- Roche cobas LIAT SARS-CoV-2 & Influenza A/B
- Roche cobas LIAT SARS-CoV-2, Influenza A/B & RSV
- Abbott Architect SARS-CoV-2 Total Ab
- Beckman Coulter, Inc. Access SARS CoV-2 IgG
- Diasorin LIAISON® SARS-CoV-2 S1/S2 IgG
- Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack
- Ortho-Clinical Diagnostics, Inc. VITROS Anti-SARS-CoV-2 Total Antibody
- Siemens Atellica SARS-CoV-2 Total Ab
- Siemens Dimension EXL SARS-CoV-2 Total Ab
- Siemens Dimension Centaur SARS-CoV-2 Total Ab
- Siemens Dimension Vista SARS-CoV-2 Total Ab
- bioMérieux VIDAS® SARS-COV-2 IgG
- Access Bio, Inc. CareStart™ COVID-19 Antigen
- Atellica IM SARS-CoV-2 Antigen (CoV2Ag)
- BD Veritor™ System for Rapid Detection of SARS-CoV-2
- BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B
- BinaxNOW™ COVID-19 Ag Card
- DiaSorin LIAISON® SARS-CoV-2 Ag
- INDICAID™ COVID-19 Rapid Antigen Test
- LumiraDx SARS-CoV-2 Antigen (Ag)
- Quidel QuickVue SARS Antigen
- Sofia SARS Antigen FIA
- Sofia 2 Flu + SARS Antigen FIA
- Status™ COVID 19/Flu A&B
Infectious Disease Clinical Decision Team and Laboratory Services Joint Statement on Serologic Testing for SARS-CoV-2 Antibodies (COVID-19) for Healthcare Providers
- Abbott Alinity m SARS-CoV-2 Assay
- Abbott ID Now
- BD SARS-CoV-2 Assay (standalone)
- BD SARS-CoV-2 Flu Assay (COVID/Flu)
- BioGX SARS-CoV-2 Reagents for the BD Max System
- BioFire Respiratory Panel 2.1 Panel
- CDC 2019-nCoV Real-Time-RT-PCR Diagnostic Panel
- Cepheid Xpert Xpress SARS-CoV-2 test
- Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV
- Cepheid Xpert Xpress CoV-2/Flu/RSV plus
- Diasorin Simplexa COVID-19 Direct Assay
- Hologic Aptima SARS-CoV-2 Assay
- Luminex ARIES® SARS‑CoV‑2 Assay
- QIAGEN QIAstat-Dx Respiratory SARS-CoV-2 Panel
- Roche cobas SARS-CoV-2
- Roche cobas SARS-CoV-2 & Influenza A/B
- Roche cobas LIAT SARS-CoV-2 & Influenza A/B
- Roche cobas LIAT SARS-CoV-2, Influenza A/B & RSV
- Abbott Architect SARS-CoV-2 Total Ab
- Beckman Coulter, Inc. Access SARS CoV-2 IgG
- Diasorin LIAISON™ SARS-CoV-2 S1/S2 IgG
- Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack
- Ortho-Clinical Diagnostics, Inc. VITROS Anti-SARS-CoV-2 Total Antibody
- Siemens Atellica SARS-CoV-2 Total Ab
- Siemens Dimension EXL SARS-CoV-2 Total Ab
- Siemens Dimension Centaur SARS-CoV-2 Total Ab
- Siemens Dimension Vista SARS-CoV-2 Total Ab
- bioMérieux VIDAS® SARS-COV-2 IgG
- Access Bio, Inc. CareStart™ COVID-19 Antigen
- Atellica IM SARS-CoV-2 Antigen (CoV2Ag)
- BD Veritor™ System for Rapid Detection of SARS-CoV-2
- BD Veritor™ System for Rapid Detection of SARS-CoV-2 & Flu A+B
- BinaxNOW™ COVID-19 Ag Card
- DiaSorin LIAISON® SARS-CoV-2 Ag
- INDICAID™ COVID-19 Rapid Antigen Test
- LumiraDx SARS-CoV-2 Antigen (Ag)
- Quidel QuickVue SARS Antigen
- Sofia SARS Antigen FIA
- Sofia 2 Flu + SARS Antigen FIA
- Status™ COVID 19/Flu A&B